1 completed, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Hematocrit: new trials by email Literature Review of Hematocrit trials Research Report on Hematocrit
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503) Busulfan, Fludarabine, r-ATG - Sickle Cell Disease | Phase 2 | Completed | Medical College of Wisconsin | 138 | 2017-03-16 | 2025-04-18 |
| Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas Thiotepa, Busulfan, Fludarabin - B-cell Lymphoma Refractory | Phase 2 | Unknown | Azienda Ospedaliera San Giovanni Battista | 42 | 2013-02-01 | 2014-07-08 |
Azienda Ospedaliera San Giovanni Battista (1) · Medical College of Wisconsin (1)
Italy (1) · United States (1)
Benedetto Bruno, MD (1) · Mary Eapen, MD (1)
PMID 30637784, PMID 36240296, PMID 39471440
U01HL128568 (1)